Atlas Venture Associates X, L.p. - Net Worth and Insider Trading

Atlas Venture Associates X, L.p. Net Worth

The estimated net worth of Atlas Venture Associates X, L.p. is at least $293 Million dollars as of 2024-11-06. Atlas Venture Associates X, L.p. is the 10% Owner of Kymera Therapeutics Inc and owns about 5,763,012 shares of Kymera Therapeutics Inc (KYMR) stock worth over $275 Million. Atlas Venture Associates X, L.p. is also the 10% Owner of Generation Bio Co and owns about 8,279,484 shares of Generation Bio Co (GBIO) stock worth over $18 Million. Details can be seen in Atlas Venture Associates X, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Atlas Venture Associates X, L.p. has not made any transactions after 2021-09-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Atlas Venture Associates X, L.p.

To

Atlas Venture Associates X, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Associates X, L.p. owns 8 companies in total, including Kymera Therapeutics Inc (KYMR) , Generation Bio Co (GBIO) , and Avrobio Inc (AVRO) among others .

Click here to see the complete history of Atlas Venture Associates X, L.p.’s form 4 insider trades.

Insider Ownership Summary of Atlas Venture Associates X, L.p.

Ticker Comapny Transaction Date Type of Owner
KYMR Kymera Therapeutics Inc 2021-08-11 10 percent owner
GBIO Generation Bio Co 2021-09-29 10 percent owner
AVRO Avrobio Inc 2018-06-20 10 percent owner
LIMIT LIMIT 2018-06-20 10 percent owner
LIMIT LIMIT 2018-07-19 10 percent owner
LIMIT LIMIT 2022-12-29 10 percent owner
LIMIT LIMIT 2021-03-25 10 percent owner
LIMIT LIMIT 2021-05-26 10 percent owner

Atlas Venture Associates X, L.p. Latest Holdings Summary

Atlas Venture Associates X, L.p. currently owns a total of 2 stocks. Among these stocks, Atlas Venture Associates X, L.p. owns 5,763,012 shares of Kymera Therapeutics Inc (KYMR) as of August 11, 2021, with a value of $275 Million and a weighting of 93.81%. Atlas Venture Associates X, L.p. also owns 8,279,484 shares of Generation Bio Co (GBIO) as of September 29, 2021, with a value of $18 Million and a weighting of 6.19%.

Latest Holdings of Atlas Venture Associates X, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KYMR Kymera Therapeutics Inc 2021-08-11 5,763,012 47.69 274,838,042
GBIO Generation Bio Co 2021-09-29 8,279,484 2.19 18,132,070

Holding Weightings of Atlas Venture Associates X, L.p.


Atlas Venture Associates X, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Atlas Venture Associates X, L.p. has made a total of 2 transactions in Kymera Therapeutics Inc (KYMR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Kymera Therapeutics Inc is the sale of 242,133 shares on August 11, 2021, which brought Atlas Venture Associates X, L.p. around $15 Million.

According to the SEC Form 4 filings, Atlas Venture Associates X, L.p. has made a total of 6 transactions in Generation Bio Co (GBIO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Generation Bio Co is the sale of 81,088 shares on September 29, 2021, which brought Atlas Venture Associates X, L.p. around $2 Million.

Insider Trading History of Atlas Venture Associates X, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Atlas Venture Associates X, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Atlas Venture Associates X, L.p. Ownership Network

Ownership Network List of Atlas Venture Associates X, L.p.

No Data

Ownership Network Relation of Atlas Venture Associates X, L.p.

Insider Network Chart

Atlas Venture Associates X, L.p. Owned Company Details

What does Kymera Therapeutics Inc do?

Who are the key executives at Kymera Therapeutics Inc?

Atlas Venture Associates X, L.p. is the 10 percent owner of Kymera Therapeutics Inc. Other key executives at Kymera Therapeutics Inc include Chief Medical Officer Jared Gollob , Chief Operating Officer Jeremy G Chadwick , and 10 percent owner Atlas Venture Fund X, L.p. .

Kymera Therapeutics Inc (KYMR) Insider Trades Summary

Over the past 18 months, Atlas Venture Associates X, L.p. made no insider transaction in Kymera Therapeutics Inc (KYMR). Other recent insider transactions involving Kymera Therapeutics Inc (KYMR) include a net sale of 961,800 shares made by Bruce Booth , a net sale of 89,481 shares made by Jared Gollob , and a net sale of 20,000 shares made by Jeffrey W. Albers .

In summary, during the past 3 months, insiders sold 18,500 shares of Kymera Therapeutics Inc (KYMR) in total and bought 1 shares, with a net sale of 18,499 shares. During the past 18 months, 1,456,442 shares of Kymera Therapeutics Inc (KYMR) were sold and 414,106 shares were bought by its insiders, resulting in a net sale of 1,042,336 shares.

Kymera Therapeutics Inc (KYMR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kymera Therapeutics Inc Insider Transactions

No Available Data

Atlas Venture Associates X, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Atlas Venture Associates X, L.p.. You might contact Atlas Venture Associates X, L.p. via mailing address: 400 Technology Sq., 10th Floor, Cambridge Ma 02139.